Rezilient Health is a technology company.
Rezilient is direct primary and specialty care for employers who want their healthcare benefits to actually work for them, and their people.
Rezilient Health has raised $10.0M across 1 funding round.
Rezilient Health has raised $10.0M in total across 1 funding round.
Rezilient Health is a St. Louis-based healthcare technology company that delivers unlimited primary and specialty care through a hybrid model of CloudClinics and telehealth, targeting employers to reduce healthcare costs and improve employee outcomes.[1][2][3][4] It serves businesses by offering a flat monthly fee per employee for same-day access to virtual and in-person care, including labs, imaging, and specialist consultations via remote physician "beaming" and digital diagnostics, solving high premiums, ER overuse, and access delays in traditional healthcare.[2][4][5] The company demonstrates strong growth momentum with hundreds of businesses as customers, proven clinical outcomes in the top 90th percentile nationally, high utilization rates, and significant cost savings through reduced hospitalizations.[4]
Rezilient Health was founded in 2016 in Saint Louis, Missouri, originally as DynamicSurgical, by Danish Nagda, MD (an ENT physician and CEO) and Jeff Gamble, PhD (a tech leader), alongside a team of physicians, engineers, and caregivers motivated by flaws in the existing healthcare system.[1][3][5][6] Nagda's personal medical background and experiences with care delivery gaps inspired a scalable hybrid model blending in-person relationships with telehealth accessibility, using proprietary video platforms and robotics for specialist care near where people work, live, and shop.[3][5][6] Early recognition came as an ANA Avatar XPRIZE finalist and Techstars Future of Longevity portfolio company (funded by Melinda French Gates' Pivotal Ventures), with pivotal expansion including partnerships like WakeMed Health & Hospitals for "Rezilient with WakeMed" CloudClinics.[3][6]
Rezilient rides the hybrid care wave in digital health, merging telehealth's scalability with in-person trust amid post-pandemic demand for convenient, cost-effective primary/specialty access near workplaces and communities.[1][2][6] Timing aligns with employer frustration over rising premiums and fragmented "point solutions" (e.g., mental health or diabetes apps), positioning Rezilient as a comprehensive "front door" that integrates with existing plans.[2][4][6] Market forces like labor shortages for physicians and value-based care shifts favor its remote beaming model, reducing staffing barriers and enabling nationwide reach; it influences the ecosystem by pioneering diagnostic robotics and coordinated teams, potentially lowering total care costs for businesses while boosting employee health cultures.[1][3][5]
Rezilient is poised to expand its CloudClinic footprint through strategic partnerships like WakeMed, scaling to more employers amid a shift from volume-based to outcome-driven care.[6] Trends like AI-enhanced diagnostics, further telehealth reimbursement, and employer-led benefits innovation will amplify its model, potentially capturing share from pure virtual players like Transcarent or 98point6 by emphasizing hybrid accessibility.[1] Its influence may evolve into a platform leader, redefining benefits as predictable, high-ROI investments that keep workforces healthy—proving healthcare can prioritize people over premiums, as envisioned from its founding.[4][5]
Rezilient Health has raised $10.0M in total across 1 funding round.
Rezilient Health's investors include Acorn Pacific Ventures, Cultivation Capital, FINTOP Capital, Jason Towns.
Rezilient Health has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Series A in October 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2024 | $10.0M Series A | Acorn Pacific Ventures, Cultivation Capital, FINTOP Capital, Jason Towns |